Arrowhead Pharmaceuticals
ARWRArrowhead Pharmaceuticals is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for Hepatitis B, the liver disease associated with alpha 1-antitryps …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Arrowhead Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 4/23/2026 | Sell | Hamilton, James C. | Chief Medical Officer | $75.0 | $750,000 |
| 4/22/2026 | Sell | Apel, Daniel Joseph | Chief Financial Officer | $70.8 | $934,286 |
| 3/5/2026 | Sell | Hamilton, James C. | Chief Medical Officer | $64.2 | $641,900 |
| 1/5/2026 | Sell | O'brien, Patrick | COO | $63.9 | $3,123,349 |
| 1/5/2026 | Sell | Hamilton, James C. | Chief Medical Officer | $64.1 | $2,534,661 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)